CLINICAL FEATURES AND RISK FACTORS FOR CLEVUDINE RESISTANCE IN TREATMENT-NAiVE CHRONIC HEPATITIS B PATIENTS

被引：0
|
作者：
Yim, Hyung Joon [1 ]
Kim, Jeong Han [1 ]
Choi, You-me [1 ]
Jung, Young Kul [1 ]
Jung, Eun Suk [1 ]
Kim, Ji Hoon [1 ]
Seo, Yeon Seok [1 ]
Yeon, Jong Eun [1 ]
Byun, Kwan Soo [1 ]
Um, Soon Ho [1 ]
Ryu, Ho Sang [1 ]
机构：
[1] Korea Univ, Coll Med, Seoul 136705, South Korea
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
465
引用
收藏
页码：525A / 525A
页数：1
相关论文
共 50 条
  • [1] THE COMPARISON OF 24 WEEKS TREATMENT EFFICACY BETWEEN ENTECAVIR AND CLEVUDINE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B
    Sul, Hye Ryoung
    Kim, Hyung Joon
    Lee, Hyun Woong
    Kim, Sung Jin
    Chung, Sun Joo
    Hwang, Seung Jae
    Choi, Chang Hwan
    Kim, Jung Uk
    Do, Jae Hyuk
    Chang, Sae Kyung
    Park, Sill Moo
    HEPATOLOGY, 2008, 48 (04) : 715A - 715A
  • [2] Predicting hepatitis B flare in treatment-naive patients with chronic hepatitis B
    Con, D.
    Tu, S.
    Clayton-Chubb, D.
    Lubel, J.
    Nicoll, A.
    Bloom, S.
    Sawhney, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 56 - 56
  • [3] Potential antiviral drug resistance mutations in patients with treatment-naive chronic hepatitis B
    Cakal, Bulent
    Cavus, Bilger
    Poda, Mehves
    Atasoy, Alp
    Bulakci, Mesut
    Gulluoglu, Mine
    Akyuz, Filiz
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2024, 15 (03): : 182 - 187
  • [4] COMPARISON OF TREATMENT EFFICACY OF CLEVUDINE TO ENTECAVIR FOR ANTIVIRAL NAIVE CHRONIC HEPATITIS B PATIENTS
    Kim, S. B.
    Song, I. H.
    Lee, H. I.
    Yang, H. Y.
    Kim, A. N.
    Chae, H. B.
    Lee, S. H.
    Kim, H. S.
    Lee, T. H.
    Kang, Y. W.
    Lee, E. S.
    Kim, S. H.
    Lee, B. S.
    Lee, H. Y.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S291 - S291
  • [5] Primary resistance to Hepatitis B Virus in the treatment-naive Patients
    Altindis, M.
    Demir, L.
    Uslan, I.
    Mehmet, Ozdemir
    Baykan, M.
    Kosecik, M.
    JOURNAL OF CLINICAL VIROLOGY, 2015, 70 : S118 - S118
  • [6] A COMPARISON OF 24 WEEKS AND 48 WEEKS TREATMENT EFFICACY BETWEEN CLEVUDINE AND ENTECAVIR THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B
    Shin, S. R.
    Lee, D. H.
    Song, S. M.
    Choi, M. S.
    Lee, J. H.
    Koh, K. C.
    Paik, S. W.
    Yoo, B. C.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S11 - S11
  • [7] Genotyping of HBV and tracking of resistance mutations in treatment-naive patients with chronic hepatitis B
    Pacheco, Sidelcina Rugieri
    Magalhaes Andrade dos Santos, Maria Isabel
    Stocker, Andreas
    Sant'Anna Zarife, Maria Alice
    Schinoni, Maria Isabel
    Parana, Raymundo
    dos Reis, Mitermayer Galvao
    Silva, Luciano Kalabric
    INFECTION AND DRUG RESISTANCE, 2017, 10 : 201 - 207
  • [8] Entecavir therapy for treatment-naive chronic hepatitis B patients in Taiwan
    Dai, C.
    Yeh, M.
    Huang, C.
    Huang, C.
    Hou, N.
    Hsieh, M.
    Huang, J.
    Lin, Z.
    Chen, S.
    Tsai, J.
    Yu, M.
    Chuang, W.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 : 25 - 26
  • [9] Treatment of chronic hepatitis C in treatment-naive patients
    Ferreira, Marcelo Simao
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 : 45 - 49
  • [10] Investigation of Baseline Antiviral Resistance in Treatment-Naive Chronic Hepatitis B Cases
    Ergunay, Koray
    Kahramanoglu Aksoy, Evrim
    Simsek, Hails
    Alp, Alpaslan
    Sener, Burcin
    Tatar, Gonca
    Us, Durdal
    Hascelik, Gulsen
    MIKROBIYOLOJI BULTENI, 2013, 47 (04): : 628 - 635
12345